Мировой рынок нейродиагностики – тенденции отрасли и прогноз до 2029 года

 Анализ и размер рынка нейродиагностики

По данным Института показателей и оценки глобального бремени болезней (Global Burden of Disease/Institute for Health Metrics and Evaluation), неврологические заболевания были основной причиной утраты лет жизни с поправкой на инвалидность (DALY) (примерно 276 миллионов) и смертности во всем мире в 2016 году (примерно 9 миллионов человек). Кроме того, Всемирная организация здравоохранения (ВОЗ) прогнозирует, что число людей, страдающих неврологическими заболеваниями, увеличится с 95 миллионов в 2015 году до 103 миллионов к 2030 году.

По данным Data Bridge Market Research, рынок нейродиагностики, объем которого в 2021 году составил 7,28 млрд долларов США, к 2029 году, как ожидается, достигнет 12,79 млрд долларов США при среднегодовом темпе роста 7,3% в прогнозируемый период с 2022 по 2029 год. Помимо информации о рыночных сценариях, таких как рыночная стоимость, темпы роста, сегментация, географический охват и основные игроки, рыночные отчеты, подготовленные Data Bridge Market Research, также включают в себя углубленный экспертный анализ, эпидемиологию пациентов, анализ воронки продаж, анализ цен и нормативную базу.

Масштаб и сегментация рынка нейродиагностики  

Market Definition

Neurodiagnostic tests are typically administered to patients suffering from central nervous system disorders (brain and the spinal cord). These tests monitor and record the electrical activity of the brain, spinal cord, and peripheral nerves to ensure that the disease is diagnosed as soon as possible and as accurately as possible. To provide more detailed diagnostic information, specialized imaging procedures can aid in visualizing changes in brain activity or the amounts of a specific brain chemical.

Global Neurodiagnostics Market Dynamics

Drivers

• Increasing prevalence of neurodegenerative diseases

The global burden of neurological and neurodegenerative diseases has increased demand for effective disease diagnosis. According to the World Health Organization, neurological disorders account for 12% of all deaths worldwide. Furthermore, it is estimated that 276 million people worldwide suffer from various disorders such as Alzheimer's, strokes, epilepsy, migraine, and among others. The market for neurodiagnostics will be promising and lucrative growth in the coming years, due to the increasing incidence of neurological disorders and the growing need for early diagnosis

• Technological advancements in the neurodiagnostics

Diagnostic imaging manufacturers are investing in incorporating technological advancements into their modalities that can help accurately diagnose neurological disorders. For instance, Medtronic PLC's Stealth Station S8 Neurosurgery System provides clear visualization and surgical navigation of every segment of the spine. It includes technologies such as 3D cameras, electromagnetic sensors, tracking algorithms, data processing software, and much more. Such technologies simplify the entire diagnostic process, propelling the global neurodiagnostics market.

Opportunities

• Rising prevalence of epilepsy

According to the World Health Organization, an estimated five million people worldwide are diagnosed with epilepsy each year. Epilepsy is expected to affect 50 out of every 100,000 people in high-income countries yearly. In low- and middle-income countries, this rate can reach 140 per 100,000. This is most likely due to an increased risk of recurring neurological illnesses, a higher frequency of traffic accidents and birth-related traumas, differences in healthcare technology, and the availability of preventative health programmes and affordable care. These are the factors which propel the growth of the market.

Restraints/Challenges

• High cost of diagnosis and imaging technologies

Adoption of imaging technologies necessitates significant investment, and the high cost of these technologies limits their use, particularly in developing and low-income countries' healthcare facilities. An ultrasound machine can range in price from USD 20,000 to USD 200,000, with some machines costing even more.

On the other hand, A PET scanner costs approximately USD 2 million, while an MRI scanner costs approximately USD 1 million. These amounts are regarded as prohibitively expensive, limiting adoption and market growth.

This neurodiagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the neurodiagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Neurodiagnostics Market

The COVID-19 pandemic placed a tremendous strain on the entire healthcare system. A lack of medical resources was impairing the COVID-19 outbreak, and more people became infected daily. As a result, healthcare facilities began to invest in acquiring respiratory support devices such as life support machines, oxygen generators, ventilators, PPE kits, masks, and gloves, among others. As a result, demand for the neurodiagnostics market fell significantly, negatively impacting the global neurodiagnostics market. Furthermore, the manufacturing of such devices was hampered by lockdown and social distancing protocols, resulting in significant losses for the manufacturers.

Recent developments

• In May 2021, Sense Neuro Diagnostics, a medical tech startup based in the United States, announced a strategic collaboration with Inflect Health, a venture capital health, to develop devices to improve the outcomes of stroke and brain injury patients.
• In December 2021, Rhythmlink International LLC, a medical equipment manufacturer based in the United States, announced the acquisition of Chalgren Enterprises (a medical device manufacturer) to expand its product portfolio of brain and nervous system monitoring.

Global Neurodiagnostics Market Scope

The neurodiagnostics market is segmented on the basis of product, condition, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

  Product

• Diagnostic Imaging Systems
• Ultrasound Imaging Systems
• EEG Systems
• MEG Devices
• MRI Systems
• Angiography Systems
• PET Scanners
• CT Scanners
• EMG Devices
• Other Diagnostic Imaging Systems 
• Clinical Diagnostic Instruments
• Instruments
• NGS Instruments
• Sanger Sequencers
• Other Clinical Diagnostic Instruments
• Reagents and Consumables
• Media and Sera
• Probes
• Antibodies
• Enzymes, Proteins and Peptides
• Buffers
• Solvents
• Other Reagents and Consumables

Condition

• Neurodegenerative Diseases
• Headache Disorders
• Stroke
• Sleep Disorders
• Epilepsy
•  Neuroimaging Technologies
• Computed Tomography (CT)
• Magnetic Resonance Imaging (MRI)
• Nuclear Medicine Imaging (PET, SPECT)
• Near Infrared Spectroscopic Imaging (NIRS)
• Electroencephalography (EEG)
• Magnetoencephalography (MEG)
• Voxel-based Morphometry (VBM)
• In Vitro Diagnostics
• Neuroinformatics

End-User

• Hospitals and Surgical Centers
• Ambulatory Care Settings
• Diagnostic Laboratories and Imaging Centers
• Neurology Centers
• Academic and Research Institutes

Neurodiagnostics Market Regional Analysis/Insights

The neurodiagnostics market is analyzed and market size insights and trends are provided by country, product, condition, and end user as referenced above.

The countries covered in the neurodiagnostics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the neurodiagnostics market due to the high prevalence of improved healthcare facilities, easy availability of advanced tools, and large number of manufacturing companies.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to the neurological and neurodegenerative diseases.

Раздел отчета по странам также содержит отдельные факторы, влияющие на рынок, и изменения в регулировании на внутреннем рынке, которые влияют на текущие и будущие тенденции рынка. Такие данные, как анализ цепочки создания стоимости вверх и вниз по течению, технические тенденции и анализ пяти сил Портера, тематические исследования — вот некоторые из указателей, используемых для прогнозирования рыночного сценария для отдельных стран. Кроме того, при предоставлении прогнозного анализа данных по странам учитываются наличие и доступность глобальных брендов и их проблемы, связанные с большой или малой конкуренцией со стороны местных и отечественных брендов, влияние внутренних тарифов и торговых путей.

Рост инфраструктуры здравоохранения, установленная база и проникновение новых технологий

Рынок нейродиагностики также предоставляет вам подробный анализ рынка для каждой страны по росту расходов на здравоохранение для капитального оборудования, установленной базы различных видов продукции для рынка нейродиагностики, влияния технологий с использованием кривых линии жизни и изменений в сценариях регулирования здравоохранения и их влияния на рынок нейродиагностики. Данные доступны за исторический период 2010-2020 гг.

Анализ конкурентной среды и доли рынка нейродиагностики

Конкурентная среда рынка нейродиагностики содержит данные по конкурентам. Включены сведения о компании, финансах компании, полученном доходе, рыночном потенциале, инвестициях в исследования и разработки, новых рыночных инициативах, глобальном присутствии, производственных площадках и объектах, производственных мощностях, сильных и слабых сторонах компании, запуске продукта, широте и широте продукта, доминировании приложений. Приведенные выше данные касаются только фокуса компаний на рынке нейродиагностики.

Некоторые из основных игроков, работающих на рынке нейродиагностики:

• General Electric (США)
• Конинклийке Philips NV (Нидерланды)
• Siemens Healthcare GmbH (Германия)
• Canon Inc. (Япония)
• Lifelines Neuro (США)
• Натус Медикал Инкорпорейтед. (НАС)
• F. Hoffmann-La Roche Ltd (Швейцария)
• FUJIFILM Holdings Corporation (Япония)
• ООО «Мицар» (Россия)
• Advanced Brain Monitoring, Inc. (США)
• Thermo Fisher Scientific, Inc. (США)
• Bio-Rad Laboratories, Inc. (США)
• QIAGEN (Германия)
• Nihon Kohden Corporation (Япония)
• ANT Neuro (Нидерланды)
• Корпорация FONAR (США)
• Фудзиребио (Япония)
• DRG INSTRUMENTS GMBH (Германия)
• Tecan Trading AG (Швейцария)
• Agilent Technologies, Inc. (США)

SKU-56158